Get the Stockscreener App
7.72
5.97%
-0.49
Coeptis Therapeutics Holdings Inc Stock (COEP) Forecast
The Coeptis Therapeutics Holdings Inc (COEP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.1673, representing a -97.83% decrease from the current price of $7.72. The highest analyst price target is $0.1966, and the lowest is $0.138.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month COEP Price Target
Average 1.7221
(-77.69% Downside)
Is Coeptis Therapeutics Holdings Inc (COEP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.03 | Neutral |
| STOCH(9,6) | 10.04 | Buy |
| STOCHRSI(14) | 0.1394 | Buy |
| MACD(12,26) | -0.3662 | Sell |
| ADX(14) | 10.24 | Neutral |
| William %R | -99.53 | Buy |
| CCI(14) | -119.20 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.528
Sell
|
8.4751
Sell
|
| MA20 |
9.0493
Sell
|
8.8122
Sell
|
| MA50 |
9.309
Sell
|
9.1751
Sell
|
| MA100 |
10.02
Sell
|
8.9717
Sell
|
| MA200 |
7.2597
Buy
|
8.2918
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, COEP could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on COEP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 35.03 indicates that COEP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 10.04 indicates that COEP is oversold. This indicates that COEP price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.1394 indicates that COEP is oversold. This suggests that COEP price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 10.24 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -119.2 indicates that COEP is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term COEP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Coeptis Therapeutics Holdings Inc financial reports and earnings history, Coeptis Therapeutics Holdings Inc (COEP) stock could reach $7.9993 by 2030, $7.268 by 2040 and $31.38 by 2050. See the projected annual prices until 2050 of the Coeptis Therapeutics Holdings Inc stock below:
- Coeptis Therapeutics Holdings Inc (COEP) is expected to reach an average price of $19.01 in 2035, with a high prediction of $20.01 and a low estimate of $19.27. This indicates an $146.30% rise from the last recorded price of $7.72.
- Coeptis Therapeutics Holdings Inc (COEP) stock is projected to chart a bullish course in 2040, with an average price target of $6.3805, representing an $-17.35% surge from its current level. The forecast ranges from a conservative $6.399 to a sky-high $7.268.
- Our analysts predict Coeptis Therapeutics Holdings Inc (COEP) to jump 105.09% by 2045, soaring from $15.87 to an average price of $15.83, potentially reaching $17.04. While $15.87 is the low estimate, the potential upside is significant.
- Coeptis Therapeutics Holdings Inc (COEP) stock is expected to climb by 2050, reaching an average of $29.60, a $283.38% jump from its current level. However, a wide range of estimates exists, with high and low targets of $31.38 and $29.66, respectively, highlighting the market's uncertainty.
Coeptis Therapeutics Holdings Inc Stock (COEP) Year by Year Forecast
Coeptis Therapeutics Holdings Inc Stock (COEP) Price Forecast for 2025
Coeptis Therapeutics Holdings Inc Stock (COEP) is expected to reach an average price of $1.7221 in 2025, with a high prediction of $3.4322 and a low estimate of $0.012. This indicates an -77.69% fall from the last recorded price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $0.0424 | $0.138 | $0.1966 | -99.45% |
| August, 2025 | $0.0191 | $0.012 | $0.0261 | -99.75% |
| September, 2025 | $3.4216 | $2.5354 | $3.4322 | -55.68% |
| October, 2025 | $3.1287 | $3.3887 | $3.3025 | -59.47% |
| November, 2025 | $2.3854 | $2.4104 | $2.7941 | -69.10% |
| December, 2025 | $2.4075 | $2.522 | $2.3575 | -68.82% |
Coeptis Therapeutics Holdings Inc Stock (COEP) Price Forecast for 2026
The predicted value for Coeptis Therapeutics Holdings Inc (COEP) in 2026 is set at an average of $2.3385. Estimates vary from a peak of $4.3331 to a trough of $0.3439, indicating an -69.71% surge from the present price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.4791 | $2.4129 | $2.3891 | -67.89% |
| February, 2026 | $2.3808 | $2.4308 | $2.3645 | -69.16% |
| March, 2026 | $2.1424 | $2.2545 | $2.2962 | -72.25% |
| April, 2026 | $1.6395 | $1.7595 | $2.0379 | -78.76% |
| May, 2026 | $1.6311 | $1.4757 | $1.4749 | -78.87% |
| June, 2026 | $1.1728 | $1.2628 | $1.4166 | -84.81% |
| July, 2026 | $1.236 | $1.1783 | $1.1499 | -83.99% |
| August, 2026 | $1.1966 | $1.2396 | $1.2162 | -84.50% |
| September, 2026 | $0.9473 | $1.0136 | $1.077 | -87.73% |
| October, 2026 | $0.821 | $0.7749 | $0.7205 | -89.36% |
| November, 2026 | $0.5034 | $0.599 | $0.7357 | -93.48% |
| December, 2026 | $4.7156 | $0.3439 | $4.3331 | -38.92% |
Coeptis Therapeutics Holdings Inc Stock (COEP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Coeptis Therapeutics Holdings Inc (COEP) is $3.9611, with a high forecast of $5.9276 and a low forecast of $1.9945. This indicates an -48.69% decrease from the last price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.8956 | $5.9124 | $5.9276 | -23.63% |
| February, 2027 | $5.3981 | $5.6581 | $5.6687 | -30.08% |
| March, 2027 | $4.8037 | $4.5506 | $5.0312 | -37.78% |
| April, 2027 | $4.3862 | $4.5331 | $4.3362 | -43.18% |
| May, 2027 | $4.3287 | $4.3593 | $4.2387 | -43.93% |
| June, 2027 | $4.0444 | $4.1512 | $4.1818 | -47.61% |
| July, 2027 | $3.6068 | $3.7668 | $3.8574 | -53.28% |
| August, 2027 | $3.0693 | $3.1893 | $3.5299 | -60.24% |
| September, 2027 | $2.7049 | $2.8086 | $2.8724 | -64.96% |
| October, 2027 | $2.2674 | $2.3174 | $2.378 | -70.63% |
| November, 2027 | $2.246 | $2.3099 | $2.1599 | -70.91% |
| December, 2027 | $1.9755 | $1.9945 | $2.1411 | -74.41% |
Coeptis Therapeutics Holdings Inc Stock (COEP) Price Forecast for 2028
In 2028, Coeptis Therapeutics Holdings Inc (COEP) is projected to reach an average price of $4.5494, with a high projection of $8.423 and a low estimate of $0.6757. This indicates an -41.07% fall from the last price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.6666 | $1.7329 | $1.849 | -78.41% |
| February, 2028 | $1.4112 | $1.3974 | $1.3821 | -81.72% |
| March, 2028 | $0.9551 | $0.9651 | $1.2936 | -87.63% |
| April, 2028 | $7.2433 | $0.6757 | $6.8608 | -6.17% |
| May, 2028 | $8.155 | $8.255 | $8.423 | +5.63% |
| June, 2028 | $7.2983 | $7.5783 | $7.8467 | -5.46% |
| July, 2028 | $6.9116 | $6.6908 | $6.7991 | -10.47% |
| August, 2028 | $6.1958 | $6.3058 | $6.3624 | -19.74% |
| September, 2028 | $6.0391 | $6.0881 | $6.1174 | -21.77% |
| October, 2028 | $5.7325 | $5.8716 | $5.82 | -25.74% |
| November, 2028 | $5.1706 | $5.2366 | $5.5132 | -33.02% |
| December, 2028 | $4.3799 | $4.4299 | $4.7775 | -43.27% |
Coeptis Therapeutics Holdings Inc Stock (COEP) Price Forecast for 2029
The 2029 price forecast for Coeptis Therapeutics Holdings Inc Stock (COEP) is $5.963 on average, with a high prediction of $10.92 and a low estimate of $1.0075. This represents an -22.76% decrease from the previous price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.724 | $3.924 | $4.0807 | -51.76% |
| February, 2029 | $3.3874 | $3.4274 | $3.5149 | -56.12% |
| March, 2029 | $3.2187 | $3.2606 | $3.199 | -58.31% |
| April, 2029 | $2.824 | $2.843 | $3.0615 | -63.42% |
| May, 2029 | $2.1683 | $2.2931 | $2.6652 | -71.91% |
| June, 2029 | $1.9175 | $1.936 | $2.03 | -75.16% |
| July, 2029 | $1.3838 | $1.3938 | $1.7733 | -82.07% |
| August, 2029 | $11.14 | $1.0075 | $10.92 | +44.26% |
| September, 2029 | $10.52 | $10.62 | $10.77 | +36.28% |
| October, 2029 | $9.0439 | $9.4937 | $10.15 | +17.15% |
| November, 2029 | $8.8179 | $8.831 | $8.6725 | +14.22% |
| December, 2029 | $8.1422 | $8.2522 | $8.3466 | +5.47% |
Coeptis Therapeutics Holdings Inc Stock (COEP) Price Forecast for 2030
Coeptis Therapeutics Holdings Inc Stock (COEP) is expected to reach an average price of $7.3766 in 2030, with a high forecast of $13.41 and a low forecast of $1.3393. This signifies an -4.45% decrease from the last price of $7.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.6949 | $7.7939 | $7.9993 | -0.33% |
| February, 2030 | $7.229 | $7.282 | $7.5334 | -6.36% |
| March, 2030 | $6.6972 | $6.7632 | $7.0276 | -13.25% |
| April, 2030 | $5.7774 | $5.8274 | $6.2718 | -25.16% |
| May, 2030 | $4.96 | $5.16 | $5.4459 | -35.75% |
| June, 2030 | $4.4942 | $4.5342 | $4.7186 | -41.78% |
| July, 2030 | $4.1169 | $4.1769 | $4.2413 | -46.67% |
| August, 2030 | $3.521 | $3.569 | $3.9554 | -54.39% |
| September, 2030 | $2.8553 | $2.9801 | $3.3407 | -63.01% |
| October, 2030 | $2.3305 | $2.3428 | $2.6847 | -69.81% |
| November, 2030 | $1.6473 | $1.6611 | $2.11 | -78.66% |
| December, 2030 | $13.63 | $1.3393 | $13.41 | +76.59% |
2.13%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):